Fingerprint
Dive into the research topics of 'Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B. Allred, Li Chen, Biswasjit Das, Bose Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A. Burgess, Mahesh Seetharam, Sosipatros A. Boikos, Nam Bui, James L. Chen, Julia L. Close, Gregory M. Cote, Premal H. Thaker, S. Percy Ivy, Sminu Bose, Alan D'Andrea, Adrian Marino-Enriquez
Research output: Contribution to journal › Article › peer-review